688580 伟思医疗
已收盘 03-23 15:00:00
资讯
新帖
简况
3月20日伟思医疗跌5.64%,银河康乐股票A基金重仓该股
证券之星 · 03-20 16:19
3月20日伟思医疗跌5.64%,银河康乐股票A基金重仓该股
中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期
智通财经 · 03-16
中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期
每周股票复盘:伟思医疗(688580)现两日大宗交易合计超2100万元
证券之星 · 03-15
每周股票复盘:伟思医疗(688580)现两日大宗交易合计超2100万元
伟思医疗(688580)披露股东权益变动触及1%刻度公告,3月13日股价下跌0.68%
证券之星 · 03-13
伟思医疗(688580)披露股东权益变动触及1%刻度公告,3月13日股价下跌0.68%
3月11日伟思医疗现1253.01万元大宗交易
证券之星 · 03-11
3月11日伟思医疗现1253.01万元大宗交易
3月10日伟思医疗现5笔大宗交易 机构净买入851.1万元
证券之星 · 03-10
3月10日伟思医疗现5笔大宗交易 机构净买入851.1万元
3月3日伟思医疗跌6.82%,银河康乐股票A基金重仓该股
证券之星 · 03-03
3月3日伟思医疗跌6.82%,银河康乐股票A基金重仓该股
每周股票复盘:伟思医疗(688580)2025年净利增33.99%
证券之星 · 03-01
每周股票复盘:伟思医疗(688580)2025年净利增33.99%
伟思医疗(688580)披露2025年度业绩快报公告,2月26日股价下跌1.15%
证券之星 · 02-26
伟思医疗(688580)披露2025年度业绩快报公告,2月26日股价下跌1.15%
伟思医疗(688580.SH)2025年度归母净利润1.37亿元,同比增加33.99%
智通财经 · 02-26
伟思医疗(688580.SH)2025年度归母净利润1.37亿元,同比增加33.99%
伟思医疗新注册《强脉冲光治疗仪软件V1》项目的软件著作权
证券之星 · 02-05
伟思医疗新注册《强脉冲光治疗仪软件V1》项目的软件著作权
每周股票复盘:伟思医疗(688580)股东拟减持不超3%股份
证券之星 · 01-25
每周股票复盘:伟思医疗(688580)股东拟减持不超3%股份
伟思医疗新注册《高频电灼与电刺激仪软件V1》项目的软件著作权
证券之星 · 01-24
伟思医疗新注册《高频电灼与电刺激仪软件V1》项目的软件著作权
伟思医疗(688580)披露股东减持股份计划公告,1月19日股价下跌4.79%
证券之星 · 01-19
伟思医疗(688580)披露股东减持股份计划公告,1月19日股价下跌4.79%
国家医保局助推药械出海;减肥神药价格大跳水
21世纪经济报道 · 01-19
国家医保局助推药械出海;减肥神药价格大跳水
伟思医疗(688580.SH)股东志达创投拟减持不超3%股份
智通财经 · 01-18
伟思医疗(688580.SH)股东志达创投拟减持不超3%股份
每周股票复盘:伟思医疗(688580)股价涨幅偏离值超30%
证券之星 · 01-11
每周股票复盘:伟思医疗(688580)股价涨幅偏离值超30%
股市必读:伟思医疗(688580)登1月6日交易所龙虎榜
证券之星 · 01-07
股市必读:伟思医疗(688580)登1月6日交易所龙虎榜
伟思医疗(688580.SH):公司在脑机接口领域的新产品仍处于市场培育初期
智通财经 · 01-06
伟思医疗(688580.SH):公司在脑机接口领域的新产品仍处于市场培育初期
1月6日伟思医疗涨20.01%,华银健康生活主题灵活配置基金重仓该股
证券之星 · 01-06
1月6日伟思医疗涨20.01%,华银健康生活主题灵活配置基金重仓该股
加载更多
公司概况
公司名称:
南京伟思医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2020-07-21
主营业务:
南京伟思医疗科技股份有限公司的主营业务是医疗器械的研发、生产和销售。公司的主要产品是经颅磁刺激仪、盆底磁刺激仪、脉冲磁场治疗仪、脉冲磁恢复仪、脉冲磁塑形仪、VisheeNEO生物刺激反馈仪、MyOnyx生物刺激反馈仪、瑞翼生物刺激反馈仪、多参数生物反馈仪、团体生物反馈仪、新生儿脑电测量仪、高频电灼仪、Nd:YAG倍频皮秒激光治疗仪和科瑞达钬激光治疗机、阴道电极、直肠电极、盆底训练探头、盆底肌肉康复器、高频电极、治疗激光用石英光纤和一次性医用激光光纤。
发行价格:
67.58
{"stockData":{"symbol":"688580","market":"SH","secType":"STK","nameCN":"伟思医疗","latestPrice":49.68,"timestamp":1774249200000,"preClose":53.34,"halted":0,"volume":2095983,"delay":0,"changeRate":-0.0686,"floatShares":95771299,"shares":95771299,"eps":1.3152,"marketStatus":"已收盘","change":-3.66,"latestTime":"03-23 15:00:00","open":52.69,"high":53.34,"low":49.19,"amount":108000000,"amplitude":0.0778,"askPrice":49.73,"askSize":2,"bidPrice":49.68,"bidSize":101,"shortable":0,"etf":0,"ttmEps":1.3152,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774315800000},"marketStatusCode":5,"adr":0,"adjPreClose":53.34,"symbolType":"stock_kcb","openAndCloseTimeList":[[1774229400000,1774236600000],[1774242000000,1774249200000]],"highLimit":58.67,"lowLimit":48.01,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":95771288,"isCdr":false,"pbRate":2.87,"roa":"--","peRate":37.773723,"roe":"6.17%","epsLYR":1.0685,"committee":0.729412,"marketValue":4758000000,"turnoverRate":0.0219,"status":1,"afterMarket":{"amount":0,"volume":0,"close":49.68,"buyVolume":0,"sellVolume":0,"time":1774251237558,"indexStatus":"已收盘 03-23 15:30:00","preClose":53.34},"floatMarketCap":4758000000},"requestUrl":"/m/hq/s/688580","defaultTab":"news","newsList":[{"id":"2620866357","title":"3月20日伟思医疗跌5.64%,银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620866357","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620866357?lang=zh_cn&edition=full","pubTime":"2026-03-20 16:19","pubTimestamp":1773994741,"startTime":"0","endTime":"0","summary":"证券之星消息,3月20日伟思医疗跌5.64%,收盘报53.34元,换手率2.26%,成交量2.17万手,成交额1.19亿元。重仓伟思医疗的公募基金请见下表:该股最近90天内共有5家机构给出评级,买入评级3家,增持评级2家;过去90天内机构目标均价为60.0。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为银河基金的银河康乐股票A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000027602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2619458178","title":"中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期","url":"https://stock-news.laohu8.com/highlight/detail?id=2619458178","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619458178?lang=zh_cn&edition=full","pubTime":"2026-03-16 16:05","pubTimestamp":1773648327,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中银国际发布研报称,近日,国家药监局批准博睿康植入式脑机接口手部运动功能代偿系统创新产品注册申请,实现脑机接口全球首发上市,标志中国脑机接口产业从“技术验证”迈向“商业化落地”。投资建议随着全球首款侵入式产品获批上市,国内脑机接口产业已进入商业化验证期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300753","002173","688273","BK0077","301293","688580","301087","BK0114","BK0251","688626","BK0096","BK0236","301363"],"gpt_icon":0},{"id":"2619178382","title":"每周股票复盘:伟思医疗(688580)现两日大宗交易合计超2100万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619178382","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619178382?lang=zh_cn&edition=full","pubTime":"2026-03-15 02:45","pubTimestamp":1773513912,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘,伟思医疗报收于62.41元,较上周的56.71元上涨10.05%。本周关注点来自交易信息汇总:3月10日至11日伟思医疗连续两日发生大宗交易,合计金额超2100万元。公司公告汇总南京伟思医疗科技股份有限公司控股股东王志愚及其一致行动人南京志达创业投资中心于2026年2月9日至3月11日期间,通过集中竞价和大宗交易方式合计减持公司股份602,143股,占总股本的0.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2619198824","title":"伟思医疗(688580)披露股东权益变动触及1%刻度公告,3月13日股价下跌0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619198824","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619198824?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:23","pubTimestamp":1773393798,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘,伟思医疗报收于62.41元,较前一交易日下跌0.68%,最新总市值为59.77亿元。公司于2026年3月13日发布《关于股东权益变动触及1%刻度的提示性公告》。公告显示,控股股东王志愚及其一致行动人南京志达创业投资中心于2026年2月9日至3月11日期间,通过集中竞价和大宗交易方式合计减持公司股份602,143股,占总股本的0.63%。本次权益变动后,王志愚及其一致行动人合计持股比例由46.51%减少至45.88%,触及1%比例变动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300029640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2618948546","title":"3月11日伟思医疗现1253.01万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2618948546","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618948546?lang=zh_cn&edition=full","pubTime":"2026-03-11 17:21","pubTimestamp":1773220894,"startTime":"0","endTime":"0","summary":"证券之星消息,3月11日伟思医疗发生大宗交易,交易数据如下:近三个月该股共发生9笔大宗交易,合计成交4307.0手,折价成交9笔。该股近期无解禁股上市。截至2026年3月11日收盘,伟思医疗(688580)报收于62.5元,上涨3.25%,换手率4.49%,成交量4.3万手,成交额2.67亿元。该股近半年内有股东持股变动,合计净减持117.68万股,股东增减持明细如下表:该股最近90天内共有6家机构给出评级,买入评级3家,增持评级3家;过去90天内机构目标均价为60.0。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100028825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2618821935","title":"3月10日伟思医疗现5笔大宗交易 机构净买入851.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618821935","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618821935?lang=zh_cn&edition=full","pubTime":"2026-03-10 17:20","pubTimestamp":1773134443,"startTime":"0","endTime":"0","summary":"证券之星消息,3月10日伟思医疗发生大宗交易,交易数据如下:近三个月该股共发生5笔大宗交易,合计成交2128.0手,折价成交5笔。该股近期无解禁股上市。截至2026年3月10日收盘,伟思医疗报收于60.53元,上涨2.19%,换手率3.95%,成交量3.79万手,成交额2.27亿元。该股近半年内有股东持股变动,合计净减持117.68万股,股东增减持明细如下表:该股最近90天内共有6家机构给出评级,买入评级3家,增持评级3家;过去90天内机构目标均价为60.0。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000026832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2616175153","title":"3月3日伟思医疗跌6.82%,银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2616175153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616175153?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:40","pubTimestamp":1772527223,"startTime":"0","endTime":"0","summary":"证券之星消息,3月3日伟思医疗跌6.82%,收盘报53.8元,换手率2.6%,成交量2.49万手,成交额1.38亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A目前规模为1.41亿元,最新净值2.785,较上一交易日下跌3.0%,近一年上涨33.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300029124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2616455178","title":"每周股票复盘:伟思医疗(688580)2025年净利增33.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616455178","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616455178?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:43","pubTimestamp":1772304189,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,伟思医疗报收于58.54元,较上周的57.31元上涨2.15%。本周关注点来自业绩披露要点:伟思医疗2025年归属净利润同比增长33.99%。公司公告汇总南京伟思医疗科技股份有限公司发布2025年度业绩快报,营业总收入46,272.57万元,同比增长15.66%;营业利润15,056.42万元,同比增长35.03%;归属于母公司所有者的净利润13,663.20万元,同比增长33.99%。扣除非经常性损益的净利润同比增长44.97%。总资产190,740.00万元,同比增长4.78%;归属于母公司的所有者权益169,160.55万元,同比增长3.94%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2614602388","title":"伟思医疗(688580)披露2025年度业绩快报公告,2月26日股价下跌1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614602388","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614602388?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:34","pubTimestamp":1772116458,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘,伟思医疗报收于55.81元,较前一交易日下跌1.15%,最新总市值为53.45亿元。该股当日开盘56.77元,最高56.77元,最低55.62元,成交额达6795.6万元,换手率为1.27%。近日,南京伟思医疗科技股份有限公司发布2025年度业绩快报,营业总收入46,272.57万元,同比增长15.66%;营业利润15,056.42万元,同比增长35.03%;归属于母公司所有者的净利润13,663.20万元,同比增长33.99%。总资产190,740.00万元,同比增长4.78%;归属于母公司的所有者权益169,160.55万元,同比增长3.94%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2614580018","title":"伟思医疗(688580.SH)2025年度归母净利润1.37亿元,同比增加33.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614580018","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614580018?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:16","pubTimestamp":1772093811,"startTime":"0","endTime":"0","summary":"智通财经APP讯,伟思医疗(688580.SH)披露2025年度业绩快报,报告期,公司实现营业总收入4.63亿元,同比增加15.66%;归属于母公司所有者的净利润1.37亿元,同比增加33.99%。报告期内,公司营业收入实现稳健增长,核心产品销售实现较快增长,叠加公司注重成本管控,期间费用较去年同期有所下降,综合推动盈利水平提升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"伟思医疗(688580.SH)2025年度归母净利润1.37亿元,同比增加33.99%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688580"],"gpt_icon":0},{"id":"2609394248","title":"伟思医疗新注册《强脉冲光治疗仪软件V1》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2609394248","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609394248?lang=zh_cn&edition=full","pubTime":"2026-02-05 02:03","pubTimestamp":1770228198,"startTime":"0","endTime":"0","summary":"证券之星消息,近日伟思医疗(688580)新注册了《强脉冲光治疗仪软件V1》项目的软件著作权。今年以来伟思医疗新注册软件著作权2个。结合公司2025年中报财务数据,2025上半年公司在研发方面投入了2048.34万元,同比减28.71%。通过天眼查大数据分析,南京伟思医疗科技股份有限公司共对外投资了11家企业,参与招投标项目1558次;财产线索方面有商标信息226条,专利信息315条,著作权信息119条;此外企业还拥有行政许可177个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500001197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2606234127","title":"每周股票复盘:伟思医疗(688580)股东拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2606234127","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606234127?lang=zh_cn&edition=full","pubTime":"2026-01-25 01:53","pubTimestamp":1769277189,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,伟思医疗报收于59.35元,较上周的62.86元下跌5.58%。本周,伟思医疗1月19日盘中最高价报61.38元。1月21日盘中最低价报56.81元。伟思医疗当前最新总市值56.84亿元,在医疗器械板块市值排名68/127,在两市A股市值排名3282/5182。其中集中竞价减持不超过957,712股,大宗交易减持不超过1,915,425股,减持期间为2026年2月9日至2026年5月8日,减持原因为自身资金需求。志达创投与公司实际控制人王志愚为一致行动人,本次减持不会导致公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2605407420","title":"伟思医疗新注册《高频电灼与电刺激仪软件V1》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2605407420","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605407420?lang=zh_cn&edition=full","pubTime":"2026-01-24 02:34","pubTimestamp":1769193258,"startTime":"0","endTime":"0","summary":"证券之星消息,近日伟思医疗(688580)新注册了《高频电灼与电刺激仪软件V1》项目的软件著作权。今年以来伟思医疗新注册软件著作权1个。结合公司2025年中报财务数据,2025上半年公司在研发方面投入了2048.34万元,同比减28.71%。通过天眼查大数据分析,南京伟思医疗科技股份有限公司共对外投资了11家企业,参与招投标项目1552次;财产线索方面有商标信息226条,专利信息315条,著作权信息119条;此外企业还拥有行政许可176个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012400001184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2604184617","title":"伟思医疗(688580)披露股东减持股份计划公告,1月19日股价下跌4.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604184617","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604184617?lang=zh_cn&edition=full","pubTime":"2026-01-19 17:29","pubTimestamp":1768814955,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘,伟思医疗报收于59.85元,较前一交易日下跌4.79%,最新总市值为57.32亿元。公司近日发布公告称,股东南京志达创业投资中心持有公司6,758,338股,占总股本7.06%,计划通过集中竞价和大宗交易方式减持不超过2,873,137股,减持比例不超过公司总股本的3%。其中集中竞价减持不超过957,712股,大宗交易减持不超过1,915,425股,减持期间为2026年2月9日至2026年5月8日,减持原因为自身资金需求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900023487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2604083739","title":"国家医保局助推药械出海;减肥神药价格大跳水","url":"https://stock-news.laohu8.com/highlight/detail?id=2604083739","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604083739?lang=zh_cn&edition=full","pubTime":"2026-01-19 08:02","pubTimestamp":1768780979,"startTime":"0","endTime":"0","summary":"国家医保局助推药械出海;减肥神药价格大跳水","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601193622762816.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601193622762816.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0175","002317","BK0185","BK0251","BK0239","BK0028","BK0082","BK0188","BK0250","600056","BK0077","688580","BK0010"],"gpt_icon":0},{"id":"2604927783","title":"伟思医疗(688580.SH)股东志达创投拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2604927783","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604927783?lang=zh_cn&edition=full","pubTime":"2026-01-18 15:46","pubTimestamp":1768722400,"startTime":"0","endTime":"0","summary":"智通财经APP讯,伟思医疗(688580.SH)公告,公司股东志达创投拟通过集中竞价、大宗交易方式减持公司股份,合计减持不超过287.31万股,合计减持比例不超过公司总股本的3%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2602533072","title":"每周股票复盘:伟思医疗(688580)股价涨幅偏离值超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602533072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602533072?lang=zh_cn&edition=full","pubTime":"2026-01-11 02:10","pubTimestamp":1768068617,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,伟思医疗报收于65.7元,较上周的48.4元上涨35.74%。本周,伟思医疗1月7日盘中最高价报72.27元,股价触及近一年最高点。交易信息汇总伟思医疗因单日收盘价涨幅达15%且连续3个交易日涨幅偏离值累计达30%,于2026年1月6日登龙虎榜。为近5个交易日内首次上榜。公司公告汇总公司股票连续三日收盘价涨幅偏离值超30%,构成交易异常波动。2025年前三季度实现营业收入3.26亿元,同比增长11.58%;归母净利润1.02亿元,同比增长30.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2601120588","title":"股市必读:伟思医疗(688580)登1月6日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2601120588","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601120588?lang=zh_cn&edition=full","pubTime":"2026-01-07 02:36","pubTimestamp":1767724573,"startTime":"0","endTime":"0","summary":"来自交易信息汇总:伟思医疗因股价涨幅偏离值累计达15%及三日内累计达30%,登龙虎榜。龙虎榜上榜沪深交易所2026年1月6日公布的交易公开信息显示,伟思医疗因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券,有价格涨跌幅限制的连续3个交易日内收盘价格涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700001146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2601895803","title":"伟思医疗(688580.SH):公司在脑机接口领域的新产品仍处于市场培育初期","url":"https://stock-news.laohu8.com/highlight/detail?id=2601895803","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601895803?lang=zh_cn&edition=full","pubTime":"2026-01-06 18:02","pubTimestamp":1767693777,"startTime":"0","endTime":"0","summary":"智通财经APP讯,伟思医疗(688580.SH)发布股价异动公告称,公司主营业务聚焦于康复医疗器械的研发、生产与销售,产品广泛应用于精神康复、盆底及产后康复、神经康复等领域。截至2025年末,公司在脑机接口领域的新产品仍处于市场培育初期,主要布局非侵入式技术路线,与当前国际领先的侵入式脑机接口存在显著技术路径差异,相关产品尚未实现规模化销售,对整体营业收入的贡献仍较为有限。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389387.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2601864939","title":"1月6日伟思医疗涨20.01%,华银健康生活主题灵活配置基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601864939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601864939?lang=zh_cn&edition=full","pubTime":"2026-01-06 15:37","pubTimestamp":1767685036,"startTime":"0","endTime":"0","summary":"证券之星消息,1月6日伟思医疗涨20.01%创60日新高,收盘报69.7元,换手率10.74%,成交量10.29万手,成交额6.98亿元。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为华银基金的华银健康生活主题灵活配置。华银健康生活主题灵活配置目前规模为0.9亿元,最新净值1.286,较上一交易日上涨11.83%,近一年上涨40.09%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600020411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774253471188,"stockEarnings":[{"period":"1week","weight":-0.1453},{"period":"1month","weight":-0.0693},{"period":"3month","weight":0.1444},{"period":"6month","weight":0.0765},{"period":"1year","weight":0.4899},{"period":"ytd","weight":0.1021}],"compareEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":-0.0306},{"period":"3month","weight":0.0171},{"period":"6month","weight":0.0359},{"period":"1year","weight":0.1608},{"period":"ytd","weight":-0.003}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京伟思医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"8098人(较上一季度增加0.04%)","perCapita":"11826股","listingDate":"2020-07-21","address":"江苏省南京市雨花台区宁双路19号9栋","registeredCapital":"9577万元","survey":" 南京伟思医疗科技股份有限公司的主营业务是医疗器械的研发、生产和销售。公司的主要产品是经颅磁刺激仪、盆底磁刺激仪、脉冲磁场治疗仪、脉冲磁恢复仪、脉冲磁塑形仪、VisheeNEO生物刺激反馈仪、MyOnyx生物刺激反馈仪、瑞翼生物刺激反馈仪、多参数生物反馈仪、团体生物反馈仪、新生儿脑电测量仪、高频电灼仪、Nd:YAG倍频皮秒激光治疗仪和科瑞达钬激光治疗机、阴道电极、直肠电极、盆底训练探头、盆底肌肉康复器、高频电极、治疗激光用石英光纤和一次性医用激光光纤。","listedPrice":67.58},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"伟思医疗(688580)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供伟思医疗(688580)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"伟思医疗,688580,伟思医疗股票,伟思医疗股票老虎,伟思医疗股票老虎国际,伟思医疗行情,伟思医疗股票行情,伟思医疗股价,伟思医疗股市,伟思医疗股票价格,伟思医疗股票交易,伟思医疗股票购买,伟思医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"伟思医疗(688580)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供伟思医疗(688580)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}